Inactive Instrument

Safal Herbs Limited

532034

INE880M01020

Safal Herbs Limited Reports Earnings Results for the Third Quarter Ended December 31, 2018

February 16, 2019 at 12:03 pm

Safal Herbs Limited announced earnings results for the third quarter ended December 31, 2018. For the third quarter, the company announced total revenue was INR 1.01 million. Net income was INR 0.15 million compared to INR 0.10 million a year ago.

Latest news about Safal Herbs Limited

Safal Herbs Limited Announces Resignation of Smita Chaturvedi Company Sceretary and Compliance Officer	22-08-10	CI
Safal Herbs Limited Approves Resignation of Mr. Rajesh Chaudhary as Director	22-07-19	CI
Safal Herbs Limited Appoints Pratha Prasad as CFO	21-09-09	CI
Safal Herbs Limited Appoints Smita Chaturvedi as Company Secretary	21-09-09	CI
Safal Herbs Limited Announces Earnings Results for the First Quarter Ended June 30, 2021	21-08-13	CI
Safal Herbs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-06-25	CI
Safal Herbs Limited Announces Resignation of Amit Kumar Sodhan as Company Secretary and Compliance Officer	21-03-20	CI
Safal Herbs Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-02-12	CI
Safal Herbs Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	20-11-07	CI
Safal Herbs Limited Appoints Amit Kumar Sodhani, as A Whole-Time Company Secretary Cum Compliance Officer	20-10-27	CI
Safal Herbs Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	20-09-14	CI
Safal Herbs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	20-07-31	CI
Safal Herbs Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	20-02-11	CI
Safal Herbs Limited Appoints Hema Lalwani as A Company Secretary	20-01-08	CI
Safal Herbs Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	19-11-13	CI
Safal Herbs Limited Appoints Priya Gautam as Additional Director	19-11-06	CI
Safal Herbs Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	19-08-14	CI
Safal Herbs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019	19-06-08	CI
Safal Herbs Limited Reports Earnings Results for the Third Quarter Ended December 31, 2018	19-02-16	CI
Safal Herbs Limited Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	18-11-15	CI
Safal Herbs Limited Announces Board Changes	18-05-15	CI
Safal Herbs Limited Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017	18-02-12	CI
Safal Herbs Limited Reports Unaudited Earnings Results for the Second Quarter and Half Year Ended September 30, 2017	17-11-14	CI
Safal Herbs Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2017	17-08-12	CI
Safal Herbs Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2017	17-05-30	CI

Chart Safal Herbs Limited

Duration

Period

More charts

Company Profile

Safal Herbs Limited is an India-based company, which is engaged in the business of manufacturing, trading, importing, exporting, spinning, doubling, twisting, processing and dealing in all kinds of yarn. The Company focuses on various kinds of yarn, such as natural or manmade yarns, synthetic yarns, cotton yarns, natural fiber yarns and viscose rayon yarns. The Company focuses on other rayon blended yarns and viscose, cellulose, art silk, cotton wool, hemp, linen, and all other kind of fibrous materials. The Company offers other kind of fibers, polyester filament yarns, nylon type yarns and cord, and polypropylene staple fiber.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B

Other Pharmaceuticals